Notices. DEPARTMENT OF JUSTICE
314 words·~1 min read·
/register/2012/02/06/2012-2581A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 15, 2011, Sigma Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-2447, made application by renewal to the Drug Enforcement Administration
(DEA)to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Cathinone
(1235)I Methcathinone
(1237)I 4-methyl-N-methylcathinone
(1248)I Aminorex
(1585)I Alpha-ethyltryptamine
(7249)I Lysergic acid diethylamide
(7315)I 3,4-methylenedioxypyrovalerone
(7535)I 3,4-methylenedioxy-N-methylcathinone
(7540)I Tetrahydrocannabinols
(7370)I 4-Bromo-2,5-dimethoxyamphetamine
(7391)I 4-Bromo-2,5-dimethoxyphenethylamine
(7392)I 2,5-Dimethoxyamphetamine
(7396)I 3,4-Methylenedioxyamphetamine
(7400)I N-Hydroxy-3,4-methylenedioxyamphetamine
(7402)I 3,4-Methylenedioxy-N-ethylamphetamine
(7404)I 3,4-Methylenedioxymethamphetamine
(7405)I Psilocybin
(7437)I 5-Methoxy-N,N-diisopropyltryptamine
(7439)I 1-[1-(2-Thienyl)cyclohexyl]piperidine
(7470)I N-Benzylpiperazine
(7493)I Heroin
(9200)I Normorphine
(9313)I Amphetamine
(1100)II Methamphetamine
(1105)II Nabilone
(7379)II 1-Phenylcyclohexylamine
(7460)II Phencyclidine
(7471)II Cocaine
(9041)II Codeine
(9050)II Diprenorphine
(9058)II Ecgonine
(9180)II Levomethorphan
(9210)II Levorphanol
(9220)II Meperidine
(9230)II Metazocine
(9240)II Methadone
(9250)II Morphine
(9300)II Thebaine
(9333)II Levo-alphacetylmethadol
(9648)II Remifentanil
(9739)II Sufentanil
(9740)II Carfentanil
(9743)II Fentanyl
(9801)II The company plans to manufacture reference standards. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, **Federal Register** Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than April 6, 2012. Dated: January 26, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012-2581 Filed 2-3-12; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
Cites 1Cited by 0 across 0 sources